42082-92-8

Usage

Uses

Used in Pharmaceutical Industry:
CYCLOPROPANEMETHANOL, 1-HYDROXYis used as a key intermediate in the synthesis of various pharmaceutical compounds for its unique structural properties and reactivity in chemical reactions.
Used in Agrochemical Industry:
This chemical compound is used as a building block in the production of agrochemicals, contributing to the development of effective and innovative products for agricultural applications.
Used in Fine Chemicals Production:
CYCLOPROPANEMETHANOL, 1-HYDROXYis utilized as a reagent in the synthesis of fine chemicals, playing a crucial role in the creation of high-quality specialty chemicals for various applications.
Used in Material Science:
CYCLOPROPANEMETHANOL, 1-HYDROXYis employed in the field of material science for the development of novel polymers and materials, leveraging its unique chemical properties to create innovative and advanced materials with potential applications in various industries.

Upstream product

• 17994-25-1 1-Hydroxy-1-cyclopropanecarboxylic acid 

Relevant academic research and scientific papers

INHIBITORS OF RAF KINASES

Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF

A compound is shown in formula (I). The derivatives of the compound include a stereoisomer, a pharmaceutically acceptable salt, a solvate, a prodrug, a metabolite, a deuterated derivative. The compound is a structurally novel substituted imidazole formate derivative. Substituted imidazole formate derivatives are used in preparing a drug with sedative, hypnotic and/or anesthetic effects, as well as a drug that can control the state of epilepsy. The compound has a good inhibitory effect on the central nervous system, and provides a new option for clinical screening of and/or preparation of a drug with sedative, hypnotic and/or anesthetic effects and controlling the state of epilepsy.

N-substituted imidazole carboxylate compound, preparation method and medical uses thereof

The present invention relates to a compound represented by a general formula (I) or a stereoisomer, a solvate, a pharmaceutically acceptable salt or a eutectic, a composition, a preparation method and medical uses thereof, wherein the general formula (I) is defined in the specification, and each substituent is defined in the specification.

COMPOUNDS AND METHODS OF USE

The present invention provides novel compounds useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

2,3,5-TRISUBSTITUTED PYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2

The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).

2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2

The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.